STEPHEN P SQUINTO Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
Get free email notifications about insider trading for STEPHEN P SQUINTO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN P SQUINTO. STEPHEN P SQUINTO is EVP & Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research & Devel in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research & Development in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research and Development in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec. VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP& Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP/Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Chemomab Therapeutics Ltd. ($ANCN) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in SpringWorks Therapeutics, Inc. ($SWTX) and Head of Research and Dev in Passage BIO, Inc. ($PASG).
STEPHEN P SQUINTO in ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN P SQUINTO: EVP, Chief Global Ops. Officer, EVP, Global Ops. Officer, EVP, Head of R&D, EVP, Research & Development, EVP, Research and Development, EVP & Head of R&D, EVP & Head of Research & Devel, EVP & Head of Research, EVP, Head of Research, Executive VP& Head of
Holdings: 106,508 shares
Current Value: $13,603,202
Latest Transaction: Oct 28 2014
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEPHEN P SQUINTO in ALEXION PHARMACEUTICALS, INC.
Sentiment: All, ALXN, BOLD, ANCN, PASG, SWTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Buy | M | 10.36 | 10,000 | 103,600 | 44,873 | 34.9 K to 44.9 K (+28.68 %) |
Sep 13 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Option Exercise | S | 10.19 | 5,000 | 50,950 | 0 | |
Sep 13 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Option Exercise | S | 11.65 | 7,416 | 86,396 | 0 | |
Sep 13 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Sell | S | 60.89 | 5,000 | 304,450 | 34,873 | 39.9 K to 34.9 K (-12.54 %) |
Sep 13 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Buy | M | 10.19 | 5,000 | 50,950 | 39,873 | 34.9 K to 39.9 K (+14.34 %) |
Sep 13 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Sell | S | 60.89 | 7,416 | 451,560 | 34,873 | 42.3 K to 34.9 K (-17.54 %) |
Sep 13 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Buy | M | 11.65 | 7,416 | 86,396 | 42,289 | 34.9 K to 42.3 K (+21.27 %) |
Jul 19 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Sell | S | 51.08 | 332 | 16,959 | 34,873 | 35.2 K to 34.9 K (-0.94 %) |
Jul 13 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Sell | S | 51.91 | 249 | 12,926 | 35,205 | 35.5 K to 35.2 K (-0.70 %) |
Feb 18 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Option Exercise | S | 13.79 | 16,000 | 220,640 | 0 | |
Feb 18 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Sell | S | 46.60 | 16,000 | 745,600 | 35,454 | 51.5 K to 35.5 K (-31.10 %) |
Feb 18 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Buy | M | 13.79 | 16,000 | 220,640 | 51,454 | 35.5 K to 51.5 K (+45.13 %) |
Feb 01 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Option Exercise | A | 45.80 | 63,000 | 2,885,400 | 63,000 | |
Feb 01 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Grant | A | 0.00 | 9,000 | 0 | 35,454 | 26.5 K to 35.5 K (+34.02 %) |
Jan 21 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Sell | S | 47.22 | 332 | 15,677 | 26,454 | 26.8 K to 26.5 K (-1.24 %) |
Jan 12 2010 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of R&D | Sell | S | 47.67 | 1,465 | 69,837 | 26,786 | 28.3 K to 26.8 K (-5.19 %) |
Aug 26 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.19 | 7,000 | 71,330 | 0 | |
Aug 26 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 8.05 | 3,000 | 24,150 | 0 | |
Aug 26 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 32.25 | 35,800 | 1,154,550 | 0 | |
Aug 26 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | S | 45.00 | 45,800 | 2,061,078 | 28,251 | -17,549 to 28.3 K (-260.98 %) |
Aug 26 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.19 | 7,000 | 71,330 | 74,051 | 67.1 K to 74.1 K (+10.44 %) |
Aug 26 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 8.05 | 3,000 | 24,150 | 67,051 | 64.1 K to 67.1 K (+4.68 %) |
Aug 26 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 32.25 | 35,800 | 1,154,550 | 64,051 | 28.3 K to 64.1 K (+126.72 %) |
Aug 06 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 32.25 | 4,200 | 135,450 | 856 | |
Aug 06 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 45.00 | 4,200 | 189,000 | 28,251 | 32.5 K to 28.3 K (-12.94 %) |
Aug 06 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 32.25 | 4,200 | 135,450 | 32,451 | 28.3 K to 32.5 K (+14.87 %) |
Jul 17 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 38.96 | 317 | 12,350 | 28,251 | 28.6 K to 28.3 K (-1.11 %) |
Jul 13 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 36.93 | 318 | 11,744 | 28,250 | 28.6 K to 28.3 K (-1.11 %) |
Mar 18 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 34.25 | 2,717 | 93,057 | 28,568 | 31.3 K to 28.6 K (-8.68 %) |
Mar 18 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Gift | G | 31.67 | 1,986 | 62,897 | 31,285 | 33.3 K to 31.3 K (-5.97 %) |
Mar 12 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 32.34 | 319 | 10,316 | 33,271 | 33.6 K to 33.3 K (-0.95 %) |
Jan 28 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 35.95 | 55,000 | 1,977,250 | 55,000 | |
Jan 28 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 0.00 | 8,000 | 0 | 33,590 | 25.6 K to 33.6 K (+31.26 %) |
Jan 16 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 36.81 | 1,348 | 49,620 | 25,590 | 26.9 K to 25.6 K (-5.00 %) |
Jan 14 2009 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 34.48 | 375 | 12,930 | 26,938 | 27.3 K to 26.9 K (-1.37 %) |
Oct 31 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Gift | G | 0.00 | 3,852 | 0 | 27,313 | 31.2 K to 27.3 K (-12.36 %) |
Oct 31 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Gift | G | 0.00 | 3,852 | 0 | 31,165 | 35 K to 31.2 K (-11.00 %) |
Sep 12 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 40.20 | 319 | 12,824 | 31,165 | 31.5 K to 31.2 K (-1.01 %) |
Jul 11 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 75.75 | 159 | 12,044 | 15,742 | 15.9 K to 15.7 K (-1.00 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 20.38 | 2,000 | 40,760 | 0 | |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 16.10 | 840 | 13,524 | 0 | |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | S | 16.10 | 9,660 | 155,526 | 0 | |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 23.29 | 6,292 | 146,541 | 0 | |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 17.67 | 8,250 | 145,778 | 0 | |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 17.67 | 3,750 | 66,263 | 0 | |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.74 | 4,500 | 48,330 | 0 | |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 21.00 | 535 | 11,235 | 0 | |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 69.72 | 840 | 58,565 | 15,901 | 16.7 K to 15.9 K (-5.02 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 69.82 | 8,250 | 576,015 | 16,741 | 25 K to 16.7 K (-33.01 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 69.85 | 3,750 | 261,938 | 24,991 | 28.7 K to 25 K (-13.05 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 69.83 | 6,292 | 439,370 | 28,741 | 35 K to 28.7 K (-17.96 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 69.76 | 535 | 37,322 | 35,033 | 35.6 K to 35 K (-1.50 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 69.79 | 9,660 | 674,171 | 35,568 | 45.2 K to 35.6 K (-21.36 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 69.83 | 4,500 | 314,235 | 45,228 | 49.7 K to 45.2 K (-9.05 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 69.86 | 2,000 | 139,720 | 49,728 | 51.7 K to 49.7 K (-3.87 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 20.38 | 2,000 | 40,760 | 51,728 | 49.7 K to 51.7 K (+4.02 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 16.10 | 840 | 13,524 | 49,728 | 48.9 K to 49.7 K (+1.72 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 16.10 | 9,660 | 155,526 | 48,888 | 39.2 K to 48.9 K (+24.63 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 23.29 | 6,292 | 146,541 | 39,228 | 32.9 K to 39.2 K (+19.10 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 17.67 | 8,250 | 145,778 | 32,936 | 24.7 K to 32.9 K (+33.42 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 17.67 | 3,750 | 66,263 | 24,686 | 20.9 K to 24.7 K (+17.91 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.74 | 4,500 | 48,330 | 20,936 | 16.4 K to 20.9 K (+27.38 %) |
May 20 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 21.00 | 535 | 11,235 | 16,436 | 15.9 K to 16.4 K (+3.36 %) |
Mar 12 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 56.05 | 159 | 8,912 | 15,901 | 16.1 K to 15.9 K (-0.99 %) |
Jan 11 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 70.59 | 25,000 | 1,764,750 | 25,000 | |
Jan 11 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 69.02 | 712 | 49,142 | 16,060 | 16.8 K to 16.1 K (-4.25 %) |
Jan 11 2008 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 0.00 | 3,000 | 0 | 16,772 | 13.8 K to 16.8 K (+21.78 %) |
Nov 07 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 21.00 | 33,465 | 702,765 | 0 | |
Nov 07 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 75.03 | 1,533 | 115,021 | 13,772 | 15.3 K to 13.8 K (-10.02 %) |
Nov 07 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 75.03 | 33,465 | 2,510,879 | 15,305 | 48.8 K to 15.3 K (-68.62 %) |
Nov 07 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 21.00 | 33,465 | 702,765 | 48,770 | 15.3 K to 48.8 K (+218.65 %) |
Sep 12 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 65.31 | 209 | 13,650 | 20,303 | 20.5 K to 20.3 K (-1.02 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.74 | 2,251 | 24,176 | 4,500 | |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.74 | 5,249 | 56,374 | 0 | |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 9.50 | 8,750 | 83,125 | 0 | |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 9.00 | 8,750 | 78,750 | 0 | |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 56.50 | 20,484 | 1,157,346 | 20,512 | 41 K to 20.5 K (-49.97 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 56.90 | 4,516 | 256,960 | 40,996 | 45.5 K to 41 K (-9.92 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.74 | 2,251 | 24,176 | 45,512 | 43.3 K to 45.5 K (+5.20 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.74 | 5,249 | 56,374 | 47,763 | 42.5 K to 47.8 K (+12.35 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 9.50 | 8,750 | 83,125 | 42,514 | 33.8 K to 42.5 K (+25.92 %) |
Jul 27 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 9.00 | 8,750 | 78,750 | 33,764 | 25 K to 33.8 K (+34.98 %) |
Jul 12 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 47.66 | 14,500 | 691,070 | 14,500 | |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 9.50 | 8,750 | 83,125 | 0 | |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 9.00 | 16,250 | 146,250 | 8,750 | |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 48.50 | 25,000 | 1,212,500 | 25,014 | 50 K to 25 K (-49.99 %) |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 9.50 | 8,750 | 83,125 | 50,014 | 41.3 K to 50 K (+21.20 %) |
Jun 01 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 9.00 | 16,250 | 146,250 | 41,264 | 25 K to 41.3 K (+64.96 %) |
Apr 04 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.50 | 9,500 | 99,750 | 0 | |
Apr 04 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 43.55 | 5,896 | 256,771 | 15,514 | 21.4 K to 15.5 K (-27.54 %) |
Apr 04 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 43.60 | 518 | 22,585 | 21,410 | 21.9 K to 21.4 K (-2.36 %) |
Apr 04 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 43.57 | 300 | 13,071 | 21,928 | 22.2 K to 21.9 K (-1.35 %) |
Apr 04 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 43.52 | 2,786 | 121,247 | 22,228 | 25 K to 22.2 K (-11.14 %) |
Apr 04 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.50 | 9,500 | 99,750 | 25,014 | 15.5 K to 25 K (+61.24 %) |
Mar 14 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 37.15 | 758 | 28,160 | 15,514 | 16.3 K to 15.5 K (-4.66 %) |
Jan 17 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 41.15 | 4,000 | 164,600 | 14,500 | |
Jan 17 2007 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 0.00 | 4,000 | 0 | 16,272 | 12.3 K to 16.3 K (+32.59 %) |
Nov 14 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.50 | 8,000 | 84,000 | 8,000 | |
Nov 14 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 42.76 | 7,500 | 320,700 | 12,272 | 19.8 K to 12.3 K (-37.93 %) |
Nov 14 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 42.95 | 500 | 21,475 | 19,772 | 20.3 K to 19.8 K (-2.47 %) |
Nov 14 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.50 | 8,000 | 84,000 | 20,272 | 12.3 K to 20.3 K (+65.19 %) |
Jun 09 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 32.70 | 12,000 | 392,400 | 12,000 | |
Apr 11 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 0.00 | 4,272 | 0 | 12,272 | 8 K to 12.3 K (+53.40 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.50 | 5,000 | 52,500 | 11,875 | |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.08 | 100 | 3,508 | 8,000 | 8.1 K to 8 K (-1.23 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.06 | 500 | 17,531 | 8,100 | 8.6 K to 8.1 K (-5.81 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.06 | 500 | 17,530 | 8,600 | 9.1 K to 8.6 K (-5.49 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.05 | 948 | 33,227 | 9,100 | 10 K to 9.1 K (-9.43 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.00 | 2,952 | 103,320 | 10,048 | 13 K to 10 K (-22.71 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.50 | 5,000 | 52,500 | 13,000 | 8 K to 13 K (+62.50 %) |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 20.72 | 10,000 | 207,200 | 10,000 | |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 20.72 | 4,000 | 82,880 | 8,000 | 4 K to 8 K (+100.00 %) |
Sep 22 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 27.58 | 8,000 | 220,640 | 8,000 | |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.00 | 15,095 | 150,950 | 0 | |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.00 | 29,905 | 299,050 | 0 | |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.41 | 9,494 | 193,773 | 4,000 | 13.5 K to 4 K (-70.36 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.43 | 2,849 | 58,205 | 13,494 | 16.3 K to 13.5 K (-17.43 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.32 | 3,000 | 60,951 | 16,343 | 19.3 K to 16.3 K (-15.51 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.50 | 2,700 | 55,350 | 19,343 | 22 K to 19.3 K (-12.25 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.52 | 600 | 12,312 | 22,043 | 22.6 K to 22 K (-2.65 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.53 | 100 | 2,053 | 22,643 | 22.7 K to 22.6 K (-0.44 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.54 | 600 | 12,324 | 22,743 | 23.3 K to 22.7 K (-2.57 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.56 | 100 | 2,056 | 23,343 | 23.4 K to 23.3 K (-0.43 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.54 | 1,086 | 22,308 | 23,443 | 24.5 K to 23.4 K (-4.43 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.60 | 9,500 | 195,700 | 24,529 | 34 K to 24.5 K (-27.92 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.65 | 417 | 8,611 | 34,029 | 34.4 K to 34 K (-1.21 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.80 | 1,302 | 27,082 | 34,446 | 35.7 K to 34.4 K (-3.64 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.98 | 500 | 10,491 | 35,748 | 36.2 K to 35.7 K (-1.38 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.02 | 1,827 | 38,404 | 36,248 | 38.1 K to 36.2 K (-4.80 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.03 | 1,073 | 22,565 | 38,075 | 39.1 K to 38.1 K (-2.74 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.10 | 5,300 | 111,830 | 39,148 | 44.4 K to 39.1 K (-11.92 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.11 | 100 | 2,111 | 44,448 | 44.5 K to 44.4 K (-0.22 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.14 | 300 | 6,342 | 44,548 | 44.8 K to 44.5 K (-0.67 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.15 | 700 | 14,805 | 44,848 | 45.5 K to 44.8 K (-1.54 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.16 | 700 | 14,812 | 45,548 | 46.2 K to 45.5 K (-1.51 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.95 | 1,267 | 26,545 | 46,248 | 47.5 K to 46.2 K (-2.67 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.00 | 7,900 | 165,900 | 47,515 | 55.4 K to 47.5 K (-14.26 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.01 | 3,433 | 72,127 | 55,415 | 58.8 K to 55.4 K (-5.83 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.01 | 587 | 12,333 | 58,848 | 59.4 K to 58.8 K (-0.99 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.02 | 400 | 8,408 | 59,435 | 59.8 K to 59.4 K (-0.67 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.04 | 900 | 18,936 | 59,835 | 60.7 K to 59.8 K (-1.48 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.04 | 500 | 10,521 | 60,735 | 61.2 K to 60.7 K (-0.82 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.05 | 108 | 2,273 | 61,235 | 61.3 K to 61.2 K (-0.18 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.00 | 15,095 | 150,950 | 61,343 | 46.2 K to 61.3 K (+32.64 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.00 | 29,905 | 299,050 | 46,248 | 16.3 K to 46.2 K (+182.98 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 20.38 | 8,000 | 163,040 | 8,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 0.00 | 4,000 | 0 | 15,876 | 11.9 K to 15.9 K (+33.68 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.15 | 3,150 | 79,223 | 11,876 | 15 K to 11.9 K (-20.96 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.20 | 100 | 2,520 | 15,026 | 15.1 K to 15 K (-0.66 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.22 | 1,150 | 29,003 | 15,126 | 16.3 K to 15.1 K (-7.07 %) |